Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

Advanced Linear Devices has introduced a voltage balancing IC for series-connected pairs of 3.3V supercapacitors. Inside is a pair of mosfet-like devices with a sharp ‘knee’ in their voltage-current ...

Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Incretin-based Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Incretin-based Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...

Citation: Study suggests lean muscle mass loss can be minimized during weight loss therapy using newer incretin obesity drugs (2025, April 10) retrieved 20 April 2025 from https://medicalxpress ...

The study presents a valuable finding on the role of cholesterol-binding sites on GLP-1 receptors although the clinical ramifications are unclear and not eminent at this point. Based on the detailed ...

They are often called portable or desktop DACs (digital-to-analogue converters) as they convert the source's digital audio to the necessary headphone-friendly analogue signals. Alternatively, ...

New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for ...

Treatment of chronic HBV infection with highly effective nucleos(t)ide analogue agents, tenofovir and entecavir, is a crucial intervention that supports the global goal of elimination of HBV infection ...